Search Within

Ayca Gucalp

Formats
  1. Meeting Abstract (72)
  2. Journal Article (37)
  3. Book Section (3)
  4. Review (1)
Groups
  1. Breast Medicine Service (113)
  2. Department of Medicine (113)
  3. Solid Tumor Oncology Division (113)
  4. Survivorship Research (92)
  5. Population Sciences Research Program (49)
  6. Epidemiology and Biostatistics (46)

More Groups

People
  1. Tiffany Traina (59)
  2. Clifford Hudis (48)
  3. Neil Iyengar (29)
  4. Sujata Patil (24)
  5. Dilip Giri (20)
  6. Monica Morrow (15)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (1)
  4. 2022 (6)
  5. 2021 (3)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Cancer Research (23)
  3. Annals of Oncology (7)
  4. Breast Cancer Research and Treatment (5)
  5. Clinical Cancer Research (4)
  6. International Journal of Radiation Oncology, Biology, Physics (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (35)
  2. American Association for Cancer Research (29)
  3. Springer (11)
  4. Oxford University Press (9)
  5. Elsevier Inc. (8)
  6. Wiley Blackwell (3)

More Publishers

Results (113)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • "A tool, not a crutch': Patients with breast cancers' perceptions of the IBM Watson for Oncology clinical decision support system
    Meeting Abstract

    Hamilton, J. G.; Shuk, E.; Westerman, J. S.; Genoff, M. C.; Werk, R. S.; Pocus, V.; Hay, J. L.; Walters, C.; Elkin, E.; Gucalp, A.; more...
    Annals of Behavioral Medicine (2017)

    Fulltext@MSK | Save
  • Androgen receptor-positive, triple-negative breast cancer
    Journal Article

    Gucalp, A.; Traina, T. A.
    Cancer (2017)

    Fulltext@MSK | Save
  • Menopause is a determinant of breast aromatase expression and its associations with BMI, inflammation, and systemic markers
    Journal Article

    Brown, K. A.; Iyengar, N. M.; Zhou, X. K.; Gucalp, A.; Subbaramaiah, K.; Wang, H.; Giri, D. D.; Morrow, M.; Falcone, D. J.; Wendel, N. K.; more...
    Journal of Clinical Endocrinology and Metabolism (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Metabolic obesity, adipose inflammation and aromatase: Potential drivers of breast cancer risk in women with normal body mass index
    Meeting Abstract

    Iyengar, N. M.; Arown, K.; Khou, X.; Subbaramaiah, K.; Giri, D. D.; Gucalp, A.; Howe, L. R.; Zahid, H.; Bhardwaj, P.; Wendel, N. K.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Obesity is associated with an increase in the HIF1α-PKM2-aromatase axis in breast adipose stromal cells that is reversed by caloric restriction: Implications for obesity-related breast cancer
    Meeting Abstract

    Zahid, H.; Iyengar, N. M.; Zhou, X. K.; Chen, I. C.; Bhardwaj, P.; Gucalp, A.; Morrow, M.; Hudis, C. A.; Dannenberg, A. J.; Brown, K. A.
    Clinical Endocrinology (2017)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Proverbs-Singh, T. A.; Corben, A.; Moynahan, M. E.; Patil, S.; Boyle, L. A.; Hudis, C. A.; Traina, T. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase (Ph) 1 study of oral seviteronel (VT-464), a dual CYP17-Lyase (L) inhibitor and androgen receptor (AR) antagonist, in patients (pts) with advanced AR plus triple negative (TNBC) or estrogen receptor (ER) plus breast cancer (BC)
    Meeting Abstract

    Bardia, A.; Dacosta, N. A.; Gabrail, N. Y.; Lemon, S.; Danso, M. A.; Ali, H. Y.; Fleming, R. A.; Kurman, M. R.; Eisner, J. R.; Moore, W. R.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)(+) metastatic breast cancer (MBC): Pharmacokinetics (PK)
    Meeting Abstract

    Gucalp, A.; Corben, A.; Patil, S.; Boyle, L. A.; Hudis, C.; Traina, T. A.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save